Skip to main content

Caliper Life Sciences Inc. Directors Hit By Investor Lawsuit Over Proposed Buyout

  • If you purchased a significant amount of shares of this company you have certain options and for certain investors are short and strict deadlines running. Investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

San Diego, Sept. 13, 2011 (Shareholders Foundation) -- An investor in Caliper Life Sciences Inc. (NASDAQ: CALP) shares filed a lawsuit in effort to stop the proposed takeover of Caliper Life Sciences by PerkinElmer, Inc at $10.50 per share. If you purchased shares of Caliper Life Sciences Inc. (NASDAQ: CALP) prior to the announcement and currently hold those shares, you have certain ...



You must register (for free) or login to view the entire case.